» Articles » PMID: 35319461

Dual Signaling Via Interferon and DNA Damage Response Elicits Entrapment by Giant PML Nuclear Bodies

Overview
Journal Elife
Specialty Biology
Date 2022 Mar 23
PMID 35319461
Authors
Affiliations
Soon will be listed here.
Abstract

PML nuclear bodies (PML-NBs) are dynamic interchromosomal macromolecular complexes implicated in epigenetic regulation as well as antiviral defense. During herpesvirus infection, PML-NBs induce epigenetic silencing of viral genomes, however, this defense is antagonized by viral regulatory proteins such as IE1 of human cytomegalovirus (HCMV). Here, we show that PML-NBs undergo a drastic rearrangement into highly enlarged PML cages upon infection with IE1-deficient HCMV. Importantly, our results demonstrate that dual signaling by interferon and DNA damage response is required to elicit giant PML-NBs. DNA labeling revealed that invading HCMV genomes are entrapped inside PML-NBs and remain stably associated with PML cages in a transcriptionally repressed state. Intriguingly, by correlative light and transmission electron microscopy (EM), we observed that PML cages also entrap newly assembled viral capsids demonstrating a second defense layer in cells with incomplete first-line response. Further characterization by 3D EM showed that hundreds of viral capsids are tightly packed into several layers of fibrous PML. Overall, our data indicate that giant PML-NBs arise via combined interferon and DNA damage signaling which triggers entrapment of both nucleic acids and proteinaceous components. This represents a multilayered defense strategy to act in a cytoprotective manner and to combat viral infections.

Citing Articles

Repression of varicella zoster virus gene expression during quiescent infection in the absence of detectable histone deposition.

Wang J, Bruckner N, Weissmann S, Gunther T, Zhu S, Vogt C PLoS Pathog. 2025; 21(2):e1012367.

PMID: 39928684 PMC: 11838886. DOI: 10.1371/journal.ppat.1012367.


Membraneless organelles in health and disease: exploring the molecular basis, physiological roles and pathological implications.

Li Y, Liu Y, Yu X, Xu Y, Pan X, Sun Y Signal Transduct Target Ther. 2024; 9(1):305.

PMID: 39551864 PMC: 11570651. DOI: 10.1038/s41392-024-02013-w.


Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.

Chowdhury S, Latham K, Tran A, Carroll C, Stanton R, Weekes M J Gen Virol. 2023; 104(12).

PMID: 38063292 PMC: 10770924. DOI: 10.1099/jgv.0.001929.


Chromatin control of human cytomegalovirus infection.

Matthews S, Groves I, OConnor C mBio. 2023; 14(4):e0032623.

PMID: 37439556 PMC: 10470543. DOI: 10.1128/mbio.00326-23.


Subviral Dense Bodies of Human Cytomegalovirus Enhance Interferon-Beta Responses in Infected Cells and Impair Progeny Production.

Penner I, Buscher N, Krauter S, Plachter B Viruses. 2023; 15(6).

PMID: 37376632 PMC: 10303022. DOI: 10.3390/v15061333.


References
1.
Everett R, Chelbi-Alix M . PML and PML nuclear bodies: implications in antiviral defence. Biochimie. 2007; 89(6-7):819-30. DOI: 10.1016/j.biochi.2007.01.004. View

2.
Kim Y, Ahn J . Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog. 2015; 11(3):e1004785. PMC: 4374831. DOI: 10.1371/journal.ppat.1004785. View

3.
Rajshekar S, Yao J, Arnold P, Payne S, Zhang Y, Bowman T . Pericentromeric hypomethylation elicits an interferon response in an animal model of ICF syndrome. Elife. 2018; 7. PMC: 6261255. DOI: 10.7554/eLife.39658. View

4.
Grimwade D, Solomon E . Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr Top Microbiol Immunol. 1997; 220:81-112. DOI: 10.1007/978-3-642-60479-9_6. View

5.
Seeler J, Marchio A, Sitterlin D, Transy C, Dejean A . Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A. 1998; 95(13):7316-21. PMC: 22602. DOI: 10.1073/pnas.95.13.7316. View